HZ-V055
/ HealZen Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
HZ-V055, an oral, highly potent pan-Ras molecular glue inhibitor demonstrated robust potency in RasMut cancer models
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Preclinical • Oncology
1 to 1
Of
1
Go to page
1